Atlas FDA

Juvederm Volux XC

FDA premarket approval P110033/S089 · decided 2024-10-29

Approval details

PMA number
P110033
Supplement
S089
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Juvederm Volux XC
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2024-09-30
Decision date
2024-10-29
Days to decision
29 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Approval of updates to the hydration step in the manufacturing process

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25